Key points are not available for this paper at this time.
The type 1 angiotensin II (AT1) receptor is well characterized but the type 2 (AT2) receptor remains an enigma. We tested the hypothesis that the AT2 receptor can modulate the growth of vascular smooth muscle cells by transfecting an AT2 receptor expression vector into the balloon-injured rat carotid artery and observed that overexpression of the AT2 receptor attenuated neointimal formation. In cultured smooth muscle cells, AT2 receptor transfection reduced proliferation and inhibited mitogen-activated protein kinase activity. Furthermore, we demonstrated that the AT2 receptor mediated the developmentally regulated decrease in aortic DNA synthesis at the latter stages of gestation. These results suggest that the AT2 receptor exerts an antiproliferative effect, counteracting the growth action of AT1 receptor.
Building similarity graph...
Analyzing shared references across papers
Loading...
Masatoshi Nakajima
Tokyo University of Pharmacy and Life Sciences
Howard G. Hutchinson
AstraZeneca (United States)
Masahiko Fujinaga
University of London
Proceedings of the National Academy of Sciences
Stanford University
Building similarity graph...
Analyzing shared references across papers
Loading...
Nakajima et al. (Tue,) studied this question.
synapsesocial.com/papers/6a1be8fbfc87fd06169cea7e — DOI: https://doi.org/10.1073/pnas.92.23.10663
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: